| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |